NeonMind is dedicated to the improvement of human life through the advancement of science to engage the mind to heal the body.
Psychedelic therapy has been deemed to have potential for treating a variety of mental health illnesses, labelled a "breakthrough therapy" for the 100 million people suffering from treatment resistant depression. Studies are underway worldwide to examine the potential for psychedelics to treat many illnesses that are mind related. NeonMind is conducting research and development into therapeutic uses of psychedelics.
We are a team of scientific advisors and industry experts spanning multiple relevant areas of expertise from research and development to clinical trials through to commercialization. Our parent company, Yield Growth Corp., provides legal, operational, financial and marketing support so that we can focus exclusively on bringing healing to the masses.